{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:29:17Z","timestamp":1792661357295,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T00:00:00Z","timestamp":1516752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003668","name":"Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries","doi-asserted-by":"publisher","award":["20110258"],"award-info":[{"award-number":["20110258"]}],"id":[{"id":"10.13039\/501100003668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Korean government (MSIP)","doi-asserted-by":"publisher","award":["2016M3A9B6918973"],"award-info":[{"award-number":["2016M3A9B6918973"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bbrc.2018.01.141","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T10:17:48Z","timestamp":1517393868000},"page":"846-851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["The level of decoy epitope in PCV2 vaccine affects the neutralizing activity of sera in the immunized animals"],"prefix":"10.1016","volume":"496","author":[{"given":"Junyeong","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Hee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junho","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.01.141_bib1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.cell.2006.01.034","article-title":"Anti-immunology: evasion of the host immune system by bacterial and viral pathogens","volume":"124","author":"Finlay","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2018.01.141_bib2","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nm.1949","article-title":"Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?","volume":"15","author":"Stamatatos","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2018.01.141_bib3","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3390\/v3101870","article-title":"Feline immunodeficiency virus (FIV) neutralization: a review","volume":"3","author":"Hosie","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.bbrc.2018.01.141_bib4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1189\/jlb.4RI0214-126R","article-title":"Immune control and failure in HCV infection\u2013tipping the balance","volume":"96","author":"Dustin","year":"2014","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.bbrc.2018.01.141_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1128\/CVI.00035-12","article-title":"Xenoepitope substitution avoids deceptive imprinting and broadens the immune response to foot-and-mouth disease virus","volume":"19","author":"Szczepanek","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.bbrc.2018.01.141_bib6","doi-asserted-by":"crossref","first-page":"13473","DOI":"10.1038\/ncomms13473","article-title":"Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines","volume":"7","author":"Du","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2018.01.141_bib7","article-title":"Critical epitopes in the nucleocapsid protein of SFTS virus recognized by a panel of SFTS patients derived human monoclonal antibodies","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2018.01.141_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065548","article-title":"Signal peptide cleavage from GP5 of PRRSV: a minor fraction of molecules retains the decoy epitope, a presumed molecular cause for viral persistence","volume":"8","author":"Thaa","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2018.01.141_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000705","article-title":"The murine gammaherpesvirus-68 gp150 acts as an immunogenic decoy to limit virion neutralization","volume":"2","author":"Gillet","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2018.01.141_bib10","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1128\/CVI.00418-10","article-title":"Antibody recognition of porcine circovirus type 2 capsid protein epitopes after vaccination, infection, and disease","volume":"18","author":"Trible","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.bbrc.2018.01.141_bib11","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1016\/j.vaccine.2016.10.044","article-title":"Replacing the decoy epitope of PCV2b capsid protein with a protective epitope enhances efficacy of PCV2b vaccine","volume":"34","author":"Yu","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2018.01.141_bib12","doi-asserted-by":"crossref","first-page":"13014","DOI":"10.1038\/ncomms13014","article-title":"Structural insights into the assembly and regulation of distinct viral capsid complexes","volume":"7","author":"Sarker","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2018.01.141_bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.virol.2008.12.039","article-title":"Interaction of the replication proteins and the capsid protein of porcine circovirus type 1 and 2 with host proteins","volume":"386","author":"Finsterbusch","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.bbrc.2018.01.141_bib14","doi-asserted-by":"crossref","first-page":"13508","DOI":"10.1128\/JVI.01763-12","article-title":"Recognition of the different structural forms of the capsid protein determines the outcome following infection with porcine circovirus type 2","volume":"86","author":"Trible","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2018.01.141_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.virusres.2011.11.018","article-title":"Genetic variation of porcine circovirus type 2 (PCV2) and its relevance to vaccination, pathogenesis and diagnosis","volume":"164","author":"Trible","year":"2012","journal-title":"Virus Res."},{"key":"10.1016\/j.bbrc.2018.01.141_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tvjl.2012.06.031","article-title":"Commercial porcine circovirus type 2 vaccines: efficacy and clinical application","volume":"194","author":"Chae","year":"2012","journal-title":"Vet. J."},{"key":"10.1016\/j.bbrc.2018.01.141_bib17","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Roldao","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.bbrc.2018.01.141_bib18","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1016\/j.vaccine.2012.04.022","article-title":"Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition","volume":"30","author":"Trible","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2018.01.141_bib19","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s00705-008-0248-x","article-title":"Efficient production of type 2 porcine circovirus-like particles by a recombinant baculovirus","volume":"153","author":"Liu","year":"2008","journal-title":"Arch. Virol."},{"key":"10.1016\/j.bbrc.2018.01.141_bib20","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00253-012-4015-2","article-title":"Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development","volume":"95","author":"Wu","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbrc.2018.01.141_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11262-006-0043-2","article-title":"Expression of porcine circovirus 2 ORF2 gene requires codon optimized E.\u00a0coli cells","volume":"34","author":"Trundova","year":"2007","journal-title":"Virus Genes"},{"key":"10.1016\/j.bbrc.2018.01.141_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-1759(00)00221-0","article-title":"Methods for the generation of chicken monoclonal antibody fragments by phage display","volume":"242","author":"Andris-Widhopf","year":"2000","journal-title":"J.\u00a0Immunol. Meth."},{"key":"10.1016\/j.bbrc.2018.01.141_bib23","series-title":"Phage Display: a Laboratory Manual","author":"Barbas","year":"2001"},{"key":"10.1016\/j.bbrc.2018.01.141_bib24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bbrc.2017.09.023","article-title":"A\u00a0point mutation in the heavy chain complementarity-determining region 3 (HCDR3) significantly enhances the specificity of an anti-ROS1 antibody","volume":"493","author":"Lee","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.01.141_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2014.57","article-title":"An antibody reactive to the Gly63-Lys68 epitope of NT-proBNP exhibits O-glycosylation-independent binding","volume":"46","author":"Lee","year":"2014","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbrc.2018.01.141_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146907","article-title":"Chicken scFvs with an artificial cysteine for site-directed conjugation","volume":"11","author":"Yoon","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2018.01.141_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0003-2697(81)90281-5","article-title":"\u201cWestern blotting\u201d: electrophoretic transfer of proteins from sodium dodecyl sulfate\u2013polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A","volume":"112","author":"Burnette","year":"1981","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbrc.2018.01.141_bib28","first-page":"233","article-title":"Evaluation of commercial polyclonal- and monoclonal-antibody-based immunohistochemical tests for 2 genotypes of Porcine circovirus type 2 and comparison with in-situ hybridization assays","volume":"78","author":"Seo","year":"2014","journal-title":"Can. J. Vet. Res."},{"key":"10.1016\/j.bbrc.2018.01.141_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12985-015-0338-9","article-title":"Comparative efficacy of experimental inactivated and live-attenuated chimeric porcine circovirus (PCV) 1-2b vaccines derived from PCV1 and PCV2b isolates originated in China","volume":"12","author":"Li","year":"2015","journal-title":"Virol. J."},{"key":"10.1016\/j.bbrc.2018.01.141_bib30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0165-2427(94)90157-0","article-title":"Production, preliminary characterisation and applications of monoclonal antibodies to porcine circovirus","volume":"43","author":"Allan","year":"1994","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.bbrc.2018.01.141_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/vim.2000.13.143","article-title":"Characterization of immune response of young pigs to porcine circovirus type 2 infection","volume":"13","author":"Pogranichnyy","year":"2000","journal-title":"Viral Immunol."},{"key":"10.1016\/j.bbrc.2018.01.141_bib32","doi-asserted-by":"crossref","first-page":"6807964","DOI":"10.1155\/2017\/6807964","article-title":"Global status of porcine circovirus type 2 and its associated diseases in sub-saharan africa","volume":"2017","author":"Afolabi","year":"2017","journal-title":"Adv Virol"},{"key":"10.1016\/j.bbrc.2018.01.141_bib33","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s10529-015-1856-7","article-title":"Enhanced production of porcine circovirus type 2 (PCV2) virus-like particles in Sf9 cells by translational enhancers","volume":"37","author":"Liu","year":"2015","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.bbrc.2018.01.141_bib34","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/S0264-410X(03)00503-6","article-title":"Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins","volume":"21","author":"Blanchard","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2018.01.141_bib35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11259-007-3469-7","article-title":"Immunogenicity of empty capsids of porcine circovius type 2 produced in insect cells","volume":"31","author":"Fan","year":"2007","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.01.141_bib36","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.vaccine.2009.12.061","article-title":"Immunity conferred by an experimental vaccine based on the recombinant PCV2 Cap protein expressed in Trichoplusia ni-larvae","volume":"28","author":"Perez-Martin","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2018.01.141_bib37","first-page":"121","article-title":"Predicting flexible length linear B-cell epitopes","volume":"7","author":"El-Manzalawy","year":"2008","journal-title":"Comput. Syst. Bioinf. Conf."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18301621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18301621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T11:20:06Z","timestamp":1535109606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18301621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0006291X18301621"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.01.141","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The level of decoy epitope in PCV2 vaccine affects the neutralizing activity of sera in the immunized animals","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.01.141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}